Production of recombinant human GM-CSF-EPO hybrid proteins: in vitro biological characterization
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 59 (4) , 238-246
- https://doi.org/10.1111/j.1600-0609.1997.tb00983.x
Abstract
Selective lineage differentiation depends upon the combined action of several colony-stimulating factors. Here we describe 3 human granulocyte-macrophage colony-stimulating factor-erythropoietin (GM-CSF-EPO) hybrid proteins generated by recombination of the relevant cDNAs. The expression vector containing the murine cytomegalovirus (mCMV) promoter and dihydrofolate reductase (DHFR) gene was used for the expression of the hybrid genes in Chinese hamster ovary (CHO) cells. Purified hybrid proteins from CHO transfectant cultures induced proliferation of both EPO and GM-CSF dependent cell lines. The clonogenic test, performed on purified human hematopoietic precursor cells, indicates that the hybrid proteins are more efficient at inducing erythroid differentiation compared with the equimolar mixture of GM-CSF and EPO.Keywords
This publication has 19 references indexed in Scilit:
- High-level expression of a cDNA for human granulocyte colony-stimulating factor in Chinese hamster ovary cellsMolecular Biotechnology, 1997
- Cytokine receptor signallingNature, 1995
- OncogenesNew England Journal of Medicine, 1995
- Sequential administration of recombinant human granulocyte‐macrophage colony‐stimulating factor and human erythropoietin for treatment of myelodysplasia syndromesEuropean Journal of Haematology, 1995
- Size-exclusion chromatography in an analytical perspectiveJournal of Chromatography A, 1993
- The biochemistry and biology of the myeloid haemopoietic cell growth factorsJournal of Cell Science, 1990
- HEMOPOIETIC CELL GROWTH FACTORS AND THEIR RECEPTORSAnnual Review of Biochemistry, 1989
- The molecular control of cell division, differentiation commitment and maturation in haemopoietic cellsNature, 1989
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.Proceedings of the National Academy of Sciences, 1988
- The Human Hematopoietic Colony-Stimulating FactorsScience, 1987